The Journal of Organic Chemistry
Article
oven initial temp 60 °C (2 min), rate 4 °C/min, oven final temp 100
°C (25 min), retention times 32.44 min (R), 33.69 min (S); TOF-MS
(ESI+) calcd for [C14H26O2Si + Na]+ 277.1600, found 277.1580.
retention times 5.28 min (S), 15.2 min (R); TOF-MS (ESI+) calcd for
[C19H29BO4 + Na]+ 355.20566, found 355.20604.
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
heptyl acetate (9f): 32 mg (88% yield, 94% ee), [α]16 = +37.4 (c =
(R)-3-Acetoxy-3-cyclohexyl-1-(trimethylsilyl)-1-propyne (8g): 69
D
1.0, CHCl3); 1H NMR (300 MHz, CDCl3, ppm) δ 7.79 (d, J = 8.0 Hz,
2H), 7.32 (d, J = 7.9 Hz, 2H), 5.72 (t, J = 6.9 Hz, 1H), 2.06 (s, 3H),
1.95−1.69 (m, 2H), 1.36−1.24 (m, 20H), 0.86 (t, J = 4.7 Hz, 3H); 13C
NMR (75 MHz, CDCl3, ppm) 170.4, 144.0, 134.9, 125.8, 83.8, 76.1,
36.3, 31.7, 29.0, 25.4, 24.9, 22.6, 21.3, 14.0. HPLC conditions: (R,R)-
Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/min, UV
= 217 nm, retention times 5.44 min (S), 17.6 min (R); TOF-MS (ESI
+) calcd for [C21H33BO4+Na]+ 383.23696, found 383.23644.
DKR of 4a−q. The DKR reactions were performed with solutions
containing substrate (0.1 mmol), ISCBCL (1−3 mg), 6 (4 mol %),
K2CO3 (14 mg, 0.1 mmol), and IPA (1.5 equiv) in toluene at 25−60
°C for 24−48 h according to the standard procedure described
previously.6 The DKR reaction of 4a was carried out 25 °C and the
rest at 60 °C.
1
mg (91% yield, 84% ee); [α]17 = +69.2 (c = 1.0, CHCl3); H NMR
D
(300 MHz, CDCl3, ppm) δ 5.24 (d, J = 6.14 Hz, 1H), 2.09 (s, 3H),
1.88−1.59 (m, 6H), 1.34−0.99 (m, 5H), 0.17 (s, 9H); 13C NMR (75
MHz, CDCl3, ppm) 170.2, 101.9, 91.0, 68.7, 42.0, 28.7, 28.2, 26.4,
25.9, 25.8, 21.2, 0.0. Enantiomeric excess (ee) was determined after
deprotection of TMS and acetyl with K2CO3. GC conditions: β-dex
120, inlet temp 250 °C, FID detector temp 300 °C, oven initial temp
80 °C (2 min), rate 1 °C/min, oven final temp 130 °C (0 min),
retention times 37.86 min (S), 38.48 min (R); TOF-MS (ESI+) calcd
for [C14H24O2Si + Na]+ 275.1443, found 275.1412.
DKR of 3a−f. The DKR reactions were performed with solutions
containing substrate (0.1 mmol), ISCBCL (1−2 mg), 6 (4 mol %) or
7 (4 mol %), K2CO3 (14 mg, 0.1 mmol), and IPA (1.5 equiv) in
toluene at 25−40 °C for 24−108 h according to the standard
procedure described previously.6 Ruthenium catalyst 6 was employed
in most cases except DKR of 3c, in which 7 was used instead. The
DKR reactions of 3a,b were carried out 25 °C and the rest at 40 °C.
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
ethyl acetate (9a): 26 mg (89% yield, 98% ee); [α]25D = +103.8 (c =
(R)-1,3-Diphenylprop-2-ynyl acetate (10a): 16 mg (65% yield,
1
68% ee), [α]25 = +2.48 (c = 1.0, CHCl3); H NMR (300 MHz,
D
CDCl3, ppm) δ 7.59 (d, J = 1.58 Hz, 2H), 7.48−7.46 (m, 2 H), 7.40−
7.39 (m, 3 H), 7.38−7.32 (m, 3 H), 6.70 (s, 1H), 2.13 (s, 3H); 13C
NMR (75 MHz, CDCl3, ppm) 169.9, 137.2, 131.9, 129.0, 128.8, 128.7,
128.3, 127.8, 122.1, 87.1, 85.6, 66.1, 21.2. HPLC conditions: (R,R)-
Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 0.5 mL/min, UV
= 217 nm, retention times 14.6 min (S), 15.8 min (R); TOF-MS (ESI
+) calcd for [C17H14O2 − OAc]+ 191.08608, found 191.08575. The
product was hydrolyzed by the treatment with K2CO3 in water-MeOH
0.5, CHCl3) [lit.21 [α]24 = +81.8 (c = 1.0, CHCl3, >99% ee)]; H
1
D
NMR (300 MHz, CDCl3, ppm) δ 7.80 (d, J = 8.0 Hz, 2H), 7.35 (d, J =
7.9 Hz, 2H), 5.88 (q, J = 6.6 Hz, 1H), 2.07 (s, 3H), 1.52 (d, J = 6.6 Hz,
3H), 1.34 (s, 12H); 13C NMR (75 MHz, CDCl3, ppm) 170.3, 144.8,
135.0, 125.3, 83.8, 72.3, 24.8, 22.2, 21.3. HPLC conditions: (R,R)-
Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/min,
UV=217 nm, retention times 5.92 min (S), 19.5 min (R); TOF-MS
(ESI+) calcd for [C16H23BO4 + Na]+ 313.15871, found 313.15532.
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
propyl acetate (9b): 28 mg (92% yield, >99% ee); [α]25D = +118.4 (c
to give the corresponding alcohol: [α]25 = +3.32 (c = 1.0, CHCl3)
D
[lit.22 [α]22 = +5.1 (c = 0.5, CHCl3, 88% ee)].
D
(R)-1-(4-Fluorophenyl)-3-phenylprop-2-ynyl acetate (10b): 24 mg
(90% yield, 19% ee), [α]27D = +2.95 (c = 1.0, CHCl3); 1H NMR (300
MHz, CDCl3, ppm) δ 7.58−7.56 (m, 2H), 7.48−7.46 (m, 2H), 7.33−
7.31 (m, 3H), 7.09 (t, J = 8.62 Hz, 2H), 6.67 (s, 1H), 2.12 (s, 3H); 13C
NMR (75 MHz, CDCl3, ppm) 169.8, 164.6, 131.9, 129.9, 128.9, 128.3,
121.9, 115.8, 115.5, 87.3, 85.3, 65.4, 21.1. HPLC conditions: (R,R)-
Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/min, UV
= 217 nm, retention times 6.38 min (S), 7.00 min (R); TOF-MS (ESI
+) calcd for [C17H13FO2 − OAc]+ 209.07665, found 209.07613.
(R)-3-Phenyl-1-p-tolylprop-2-ynyl acetate (10d): 25 mg (95%
yield, 24% ee), [α]27D = +3.19 (c = 1.0, CHCl3); 1H NMR (300 MHz,
CDCl3, ppm) δ 7.50−7.46 (m, 4H), 7.32−7.30 (m, 3H), 7.21 (d, J =
7.89 Hz, 2H), 6.67 (s, 1H), 2.37 (s, 3H), 2.11 (s, 3H); 13C NMR (75
MHz, CDCl3, ppm) 169.9, 139.0, 134.3, 131.9, 129.4, 128.8, 128.3,
127.8, 122.2, 86.9, 85.8, 66.0, 21.3, 21.2. HPLC conditions: (R,R)-
Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/min, UV
= 217 nm, retention times 7.17 min (S), 7.36 min (R); TOF-MS (ESI
+) calcd for [C18H16O2 − OAc]+ 205.10173, found 205.10191.
(R)-4,4-Dimethyl-1-phenylpent-2-ynyl acetate (10g): 22 mg (97%
yield, 99% ee), [α]25D = +28.7 (c = 1.0, CHCl3); 1H NMR (300 MHz,
CDCl3, ppm) δ 7.50 (dd, J = 7.60, 1.90 Hz, 2H), 7.37−7.35 (m, 3H),
6.49 (s, 1H), 2.08 (s, 3H), 1.25 (s, 9H); 13C NMR (75 MHz, CDCl3,
ppm) 169.9, 137.8, 128.6, 127.8, 126.5, 96.3, 75.2, 65.9, 30.8, 27.5,
21.3. HPLC conditions: (R,R)-Whelk-O1, n-hexane/2-propanol = 96/
4, flow rate = 0.5 mL/min, UV = 217 nm, retention times 4.35 min
(R), 4.73 min (S). The product was hydrolyzed by the treatment with
1
= 0.5, CHCl3); H NMR (300 MHz, CDCl3, ppm) δ 7.79 (d, J = 7.7
Hz, 2H), 7.32 (d, J = 7.9 Hz, 2H), 5.66 (t, J = 6.8 Hz, 1H), 2.07 (s,
3H), 1.93−1.78 (m, 2H), 1.33 (s, 12H), 0.87 (t, J = 7.5 Hz, 3H); 13C
NMR (75 MHz, CDCl3, ppm) 170.4, 143.6, 134.9, 125.9, 83.8, 76.6,
29.2, 24.9, 21.2, 9.82. HPLC conditions: (R,R)-Whelk-O1, n-hexane/2-
propanol = 95/5, flow rate = 1.0 mL/min, UV = 217 nm, retention
times 18.5 min (R); TOF-MS (ESI+) calcd for [C17H25BO4 + Na]+
327.17436, found 327.17210.
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
but-3-enyl acetate (9c): 25 mg (78% yield, 94% ee), [α]16D = +59.7 (c
1
= 1.0, CHCl3); H NMR (300 MHz, CDCl3, ppm) δ 7.79 (d, J = 7.9
Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 5.80 (t, J = 6.8 Hz, 1H), 5.75−5.61
(m, 1H), 5.09−5.02 (m, 2H), 2.69−2.52 (m, 2H), 2.07 (s, 3H), 1.33
(s, 12H); 13C NMR (75 MHz, CDCl3, ppm) 170.2, 143.1, 134.9,
133.2, 125.8, 118.1, 83.8, 75.1, 40.7, 24.9, 21.2. HPLC conditions:
(R,R)-Whelk-O1, n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/
min, UV = 217 nm, retention times 5.45 min (S), 13.7 min (R); TOF-
MS (ESI+) calcd for [C18H25BO4+Na]+ 339.17436, found 339.17345.
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
butyl acetate (9d): 27 mg (85% yield, 94% ee), [α]14 = +76.2 (c =
D
0.5, CHCl3); 1H NMR (300 MHz, CDCl3, ppm) δ 7.79 (d, J = 8.0 Hz,
2H), 7.33 (d, J = 8.0 Hz, 2H), 5.74 (t, J = 6.9 Hz, 1H), 2.06 (s, 3H),
1.94−1.67 (m, 2H), 1.33 (s, 14H), 0.90 (t, J = 7.4 Hz, 3H); 13C NMR
(75 MHz, CDCl3, ppm) 170.3, 144.0, 134.9, 125.8, 83.8, 75.9, 38.4,
24.9, 21.3, 18.7, 13.8. HPLC condition: (R,R)-Whelk-O1, n-hexane/2-
propanol = 95/5, flow rate = 1.0 mL/min, UV = 217 nm, retention
times 5.58 min (S), 16.0 min (R); TOF-MS (ESI+) calcd for
[C18H27BO4 + Na]+ 341.19001, found 341.18906.
K2CO3 in water−MeOH to give the corresponding alcohol: [α]25
=
D
+31.0 (c = 1.0, CHCl3) [lit.22 [α]28 = +21.3 (c = 0.5, CHCl3), 75%
D
ee].
(R)-1-(4-Fluorophenyl)-4,4-dimethylpent-2-ynyl acetate (10h): 24
mg (97% yield, 95% ee), [α]25 = +29.6 (c = 0.5, CHCl3); H NMR
1
D
(300 MHz, CDCl3, ppm) δ 7.51 (dd, J = 8.77, 5.41 Hz, 2H), 7.05 (t, J
= 8.70 Hz, 2H), 6.45 (s, 1H), 2.08 (s, 3H), 1.25 (s, 9H); 13C NMR
(75 MHz, CDCl3, ppm) 168.8, 163.5, 128.6, 128.0, 114.5, 95.5, 74.0,
64.2, 29.7, 26.5, 20.2. HPLC conditions: (R,R)-Whelk-O1, n-hexane/2-
propanol = 97/3, flow rate = 0.5 mL/min, UV = 217 nm, retention
times 8.88 min (R), 9.68 min (S).
(R)-1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
pentyl acetate (9e): 29 mg (87% yield, 94% ee), [α]20 = +52.3 (c =
D
0.5, CHCl3); 1H NMR (300 MHz, CDCl3, ppm) δ 7.79 (d, J = 8.0 Hz,
2H), 7.32 (d, J = 8.0 Hz, 2H), 5.72 (t, J = 6.9 Hz, 1H), 2.06 (s, 3H),
1.95−1.70 (m, 2H), 1.39−1.12 (m, 16H), 0.86 (t, J = 4.7 Hz, 3H); 13C
NMR (75 MHz, CDCl3, ppm) 170.4, 143.9, 134.9, 125.8, 83.8, 76.1,
36.0, 27.6, 24.9, 22.4, 21.3, 13.9. HPLC conditions: (R,R)-Whelk-O1,
n-hexane/2-propanol = 95/5, flow rate = 1.0 mL/min, UV = 217 nm,
(R)-1-(4-Chlorophenyl)-4,4-dimethylpent-2-ynyl acetate (10i): 25
1
mg (96% yield, 95% ee), [α]25 = +27.3 (c = 1.0, CHCl3); H NMR
D
(300 MHz, CDCl3, ppm) δ 7.45 (d, J = 8.46 Hz, 2H), 7.33 (d, J = 8.55
2576
dx.doi.org/10.1021/jo3027627 | J. Org. Chem. 2013, 78, 2571−2578